List of Tables
Table 1. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of TREC Test
Table 3. Key Players of Complete Blood Count (CBC)
Table 4. Key Players of Genetic Test
Table 5. Key Players of Biochemical Test
Table 6. Key Players of Others
Table 7. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Region (2019-2024)
Table 11. Global Severe Combined Immunodeficiency (SCID) Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Region (2025-2030)
Table 13. Severe Combined Immunodeficiency (SCID) Diagnosis Market Trends
Table 14. Severe Combined Immunodeficiency (SCID) Diagnosis Market Drivers
Table 15. Severe Combined Immunodeficiency (SCID) Diagnosis Market Challenges
Table 16. Severe Combined Immunodeficiency (SCID) Diagnosis Market Restraints
Table 17. Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Players (2019-2024)
Table 19. Global Top Severe Combined Immunodeficiency (SCID) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis as of 2023)
Table 20. Ranking of Global Top Severe Combined Immunodeficiency (SCID) Diagnosis Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Severe Combined Immunodeficiency (SCID) Diagnosis Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Severe Combined Immunodeficiency (SCID) Diagnosis Product Solution and Service
Table 24. Date of Enter into Severe Combined Immunodeficiency (SCID) Diagnosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue Market Share by Type (2019-2024)
Table 28. Global Severe Combined Immunodeficiency (SCID) Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue Market Share by Type (2025-2030)
Table 30. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue Market Share by Application (2019-2024)
Table 32. Global Severe Combined Immunodeficiency (SCID) Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Severe Combined Immunodeficiency (SCID) Diagnosis Revenue Market Share by Application (2025-2030)
Table 34. North America Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Severe Combined Immunodeficiency (SCID) Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 49. ARCHIMEDlife Company Detail
Table 50. ARCHIMEDlife Business Overview
Table 51. ARCHIMEDlife Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 52. ARCHIMEDlife Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 53. ARCHIMEDlife Recent Development
Table 54. PerkinElmer Company Detail
Table 55. PerkinElmer Business Overview
Table 56. PerkinElmer Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 57. PerkinElmer Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 58. PerkinElmer Recent Development
Table 59. Health Research, Inc Company Detail
Table 60. Health Research, Inc Business Overview
Table 61. Health Research, Inc Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 62. Health Research, Inc Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 63. Health Research, Inc Recent Development
Table 64. Winfertility Company Detail
Table 65. Winfertility Business Overview
Table 66. Winfertility Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 67. Winfertility Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 68. Winfertility Recent Development
Table 69. Portea Medical Company Detail
Table 70. Portea Medical Business Overview
Table 71. Portea Medical Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 72. Portea Medical Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 73. Portea Medical Recent Development
Table 74. LaCAR MDX Technologies Company Detail
Table 75. LaCAR MDX Technologies Business Overview
Table 76. LaCAR MDX Technologies Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 77. LaCAR MDX Technologies Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 78. LaCAR MDX Technologies Recent Development
Table 79. Labsystems Diagnostics Oy Company Detail
Table 80. Labsystems Diagnostics Oy Business Overview
Table 81. Labsystems Diagnostics Oy Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 82. Labsystems Diagnostics Oy Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 83. Labsystems Diagnostics Oy Recent Development
Table 84. Devyser Diagnostics Company Detail
Table 85. Devyser Diagnostics Business Overview
Table 86. Devyser Diagnostics Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 87. Devyser Diagnostics Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 88. Devyser Diagnostics Recent Development
Table 89. Revcovi Company Detail
Table 90. Revcovi Business Overview
Table 91. Revcovi Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 92. Revcovi Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 93. Revcovi Recent Development
Table 94. Leadiant Biosciences Company Detail
Table 95. Leadiant Biosciences Business Overview
Table 96. Leadiant Biosciences Severe Combined Immunodeficiency (SCID) Diagnosis Product
Table 97. Leadiant Biosciences Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024) & (US$ Million)
Table 98. Leadiant Biosciences Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Type: 2023 VS 2030
Figure 3. TREC Test Features
Figure 4. Complete Blood Count (CBC) Features
Figure 5. Genetic Test Features
Figure 6. Biochemical Test Features
Figure 7. Others Features
Figure 8. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Outpatient Center Case Studies
Figure 12. Diagnostic and Research Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Severe Combined Immunodeficiency (SCID) Diagnosis Report Years Considered
Figure 15. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Region: 2023 VS 2030
Figure 18. Global Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Players in 2023
Figure 19. Global Top Severe Combined Immunodeficiency (SCID) Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Severe Combined Immunodeficiency (SCID) Diagnosis as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Severe Combined Immunodeficiency (SCID) Diagnosis Revenue in 2023
Figure 21. North America Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Country (2019-2030)
Figure 23. United States Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Country (2019-2030)
Figure 27. Germany Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Region (2019-2030)
Figure 35. China Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Country (2019-2030)
Figure 43. Mexico Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Severe Combined Immunodeficiency (SCID) Diagnosis Market Share by Country (2019-2030)
Figure 47. Turkey Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Severe Combined Immunodeficiency (SCID) Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. ARCHIMEDlife Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 50. PerkinElmer Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 51. Health Research, Inc Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 52. Winfertility Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 53. Portea Medical Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 54. LaCAR MDX Technologies Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 55. Labsystems Diagnostics Oy Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 56. Devyser Diagnostics Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 57. Revcovi Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 58. Leadiant Biosciences Revenue Growth Rate in Severe Combined Immunodeficiency (SCID) Diagnosis Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed